We have formed an international collaboration to accelerate research in the early detection of cancer including:
- The Knight Cancer Institute at Oregon Health & Science University – a leader in precision cancer medicine
- The Canary Center at Stanford – founded in 2009 as the first research center in the world, entirely dedicated to cancer early detection
- Cancer Research UK – the largest independent funder of cancer research globally
The goal of this unique trans-Atlantic agreement is to find lethal cancers as they are forming so they can be treated more effectively. Survival increases significantly when the disease is treated at an early stage.
The collaboration also seeks to accelerate progress by breaking down barriers for scientists, including:
- A lack of cohorts of sufficient size and a shortage of clinical samples available for research
- Development and deployment of new technologies
- Lack of understanding of the biology of early cancer and technologies to detect its features
2022 conference topic list includes:
- From models to mechanisms to humans
- What is needed for an earlier cancer detection test to have clinical impact?
- Microbiological risk factors for early detection
- Emerging technologies for early detection